Benefits
FODMAP digestive support (fructan-specific)
Fructans are a specific FODMAP class commonly shared across many fruits and vegetables — including wheat, onions, garlic, asparagus, artichokes, and chicory root. In laboratory conditions the enzyme breaks fructans into shorter chains and free sugars, which in theory means less material reaching the colon to be fermented into gas. That is the proposed mechanism only. The one published human trial did not show any reduction in bloating, gas or abdominal discomfort, so this remains unproven in people. Note also that wheat contains both fructans and gluten. This enzyme acts only on the fructan carbohydrate and does nothing to gluten, so it does not make wheat safe for anyone with coeliac disease or a wheat allergy.
Phase I safety and tolerability validated
Phase I safety and tolerability validated: a randomized double-blind placebo-controlled trial evaluating 2,000 INU/day found the fructanase preparation safe and well tolerated, with no significant differences in GI outcomes vs placebo. The trial was designed to look for harm, not to test whether symptoms improve, and it was run in healthy people, so it cannot tell us whether the enzyme helps anyone feel better.
FDA NDIN-granted regulatory status
Optiziome® Fructanase is one of only six fungal/microbial enzymes in the past decade to receive FDA New Dietary Ingredient Notification (NDIN). This is a regulatory filing, not a health benefit. An NDIN means the FDA received a safety notification for the ingredient and did not object to it. It is not FDA approval, and it says nothing about whether the enzyme does anything for your digestion.
Not yet tested in people who have symptoms
This is a research gap, not a benefit. The authors of the safety trial wrote that further research is warranted to find out whether microbial inulinase can reduce fructan malabsorption, digestive symptoms or intestinal inflammation in people with FODMAP sensitivity or IBS. That research has not been done. Nobody has tested this enzyme in people who actually have digestive symptoms, and a supplement is not a treatment for IBS or any other diagnosed condition.
The hope of eating a wider range of plant foods (untested)
The idea behind this enzyme is that people who react to fructans might eat a wider range of foods such as onions, garlic, asparagus and artichokes instead of staying on a restrictive elimination diet, since strict low-FODMAP diets can cut out nutritious foods. That is a hope, not a finding: no trial has shown that taking this enzyme lets anyone tolerate these foods better. Wheat is a special case, because a fructan enzyme does nothing to gluten and does not make wheat safe in coeliac disease.
Non-genetically modified, wild-type enzyme
This is a sourcing detail rather than a health benefit. The enzyme is made by a wild-type, non-genetically-modified microbial strain, which some shoppers prefer, while many other enzyme makers use genetically modified production strains. Non-GMO sourcing does not make an enzyme work better or make it more likely to ease symptoms.
Untested idea: pairing with alpha-galactosidase
This is a suggestion for future product development, not something you can rely on. The trial authors mentioned that a fructan enzyme might one day be paired with alpha-galactosidase, the enzyme used in products for beans, so that two FODMAP groups are covered at once. No such combination has been tested in people, and this enzyme has not been shown to relieve any symptom on its own.
Mechanism of action
Fructan glycosidic bond cleavage
Fructanase enzymes cleave the β-2,1 and β-2,6 glycosidic bonds in fructans — breaking the polysaccharide chains into shorter fructo-oligosaccharides and free fructose. The shorter products are more readily absorbed in the small intestine or less fermentable in the colon. This is the proposed mechanism only; it has not been shown to translate into fewer symptoms in any human trial.
Inulin (long-chain fructan) digestion
Inulin is a specific long-chain fructan with chicory root as a primary source. Often added as 'prebiotic fiber' to supplements and functional foods. Added inulin can cause gas and bloating in people who are sensitive to fructans. In laboratory conditions this enzyme breaks down inulin as well as the fructans found naturally in food, but whether that changes how anyone feels has not been tested.
Reduced colonic fermentation
Undigested fructans pass into the colon where they're fermented by gut bacteria — producing gas (CO2, hydrogen, methane) and short-chain fatty acids. While SCFAs are beneficial, the gas production causes bloating, distension, and discomfort in sensitive individuals. The idea is that pre-digesting fructans leaves less material for the colon to ferment, but no published human study has measured whether this enzyme actually reduces gas production or fermentation.
Stomach and small intestine activity
The manufacturer describes the enzyme as tolerating stomach acid and staying active in the small intestine, which is where dietary fructans arrive. None of the three references on this page measured how much of a meal's fructan content the enzyme actually breaks down inside a person, so treat this as a manufacturer description rather than a demonstrated effect.
Clinical trials
Randomized, double-blind, placebo-controlled safety and tolerability trial of 2,000 inulinase units a day (one 400 mg capsule twice daily) versus placebo for 4 weeks, following a 2-week placebo run-in. Its main measurements were safety markers: blood chemistry, blood counts, blood fats, hsCRP, insulin, lactate and uric acid, alongside a standard digestive symptom questionnaire. Published in Gastro Hep Advances in 2024 (PMID 39318719).
60 healthy adults aged 20 to 65 with no diagnosed digestive problems were enrolled and 58 completed the 4-week study. Nobody with digestive symptoms was included.
The enzyme was safe and well tolerated, and there was no significant difference in digestive outcomes compared with placebo. The researchers pointed out that the participants were healthy adults whose baseline symptoms were minimal, so a symptom difference would not be expected. This was a study of harm, not of benefit. It is the only trial of this ingredient, and it did not show the enzyme relieving anything. Studies in people who actually have fructan-related symptoms have not been done.
This entry is not a study of any kind. It is a paperwork submission: a safety dossier filed with the FDA as a New Dietary Ingredient Notification, prepared with the help of a regulatory consultancy. No one was enrolled and no health outcome was measured in people.
No participants. Nothing was measured in people.
The FDA did not object to the notification, which allows the ingredient to be sold in US supplements. That is a legal clearance about safety paperwork. It is not FDA approval, and it is not evidence of any health effect.